Incyte (INCY) Receives a Hold from Stifel Nicolaus
In a report released today, Stephen Willey from Stifel Nicolaus maintained a Hold rating on Incyte (INCY – Research Report), with a price ...
Incyte announces results from Phase 3 TRuE-PN trial
Incyte (INCY) announced results from its pivotal Phase 3 TRuE-PN clinical trial program -TRuE-PN1 and TRuE-PN2 studies – evaluating the safety ...